menu search

Kyowa kirin to acquire orchard therapeutics for $478 mln

Japanese pharmaceutical firm Kyowa Kirin said on Thursday it would acquire Britain-based bio...

October 5, 2023, 4:36 am

Why shares of conduit pharmaceuticals are jumping wednesday

Conduit just began trading on the Nasdaq on Sept. 25. The company focuses on advancing other pharmaceutical...

October 4, 2023, 12:07 pm

Kura oncology announces three presentations at aacr-nci-eortc international conference on molecular targets and cancer therapeutics

– Presentations to highlight preclinical data supporting combination of KO-2806 with targeted therapies, including TKIs, KRASG12C inhibitors and KRA...

October 4, 2023, 11:30 am

Is haemonetics (hae) stock outpacing its medical peers this year?

Here is how Haemonetics (HAE) and Amneal pharmaceuticals (AMRX) have performed compared to their sector...

October 4, 2023, 11:17 am

Eton pharmaceuticals announces acquisition of fda-approved ultra-rare disease product nitisinone

— Expect Q1 2024 product launch —— Nitisinone market estimated to be more than $50 million annually —— Eton will offer Eton Cares support pr...

October 4, 2023, 10:50 am

Eagle pharmaceuticals awarded first prize for poster to be presented at the international society for anaesthetic pharmacology 32nd annual meeting

— Study reports on an interim analysis of the pharmacokinetics and pharmacodynamics of remimazolam and a subsequent model-based optimization of the ...

October 4, 2023, 10:50 am

2 ai stocks that aren't worth the hype

Shares of Recursion pharmaceuticals and C3.ai spiked this year due to AI. Both business are unprofitabl...

October 4, 2023, 9:15 am

Teva partnership with sanofi ‘will pay dividends,' analyst says

Teva pharmaceutical Industries Ltd.'s TEVA, -4.10% new collaboration with Sanofi SNY, on an inflammator...

October 4, 2023, 8:50 am

Eli lilly exec behind diabetes blockbuster set retire

Mike Mason, the executive vice president and president of Lilly Diabetes & Obesity at Eli Lilly and Co (NYSE:LLY), is set to retire at the end of this...

October 4, 2023, 8:34 am

Karuna therapeutics to present data from the emergent program evaluating karxt in schizophrenia at the 36th european college of neuropsychopharmacology (ecnp) congress

BOSTON--(BUSINESS WIRE)--Karuna Therapeutics, Inc. (NASDAQ: KRTX), a biopharmaceutical company driven t...

October 4, 2023, 6:30 am

Sanofi to co-develop teva pharmaceutical's colitis, crohn's drug

Teva pharmaceutical Industries said on Wednesday it will collaborate with French drugmaker Sanofi to co...

October 4, 2023, 3:15 am

Io biotech announces three poster presentations at the society for immunotherapy of cancer’s (sitc) 38th annual meeting

NEW YORK, Oct. 03, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical...

October 3, 2023, 8:30 pm

Rosen, a globally recognized law firm, encourages infinity pharmaceuticals, inc. investors to secure counsel before important october 16 deadline in securities class action – infi

NEW YORK, Oct. 03, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Infinity ...

October 3, 2023, 7:36 pm

Why eli lilly stock was looking sickly today

The pharmaceutical giant signed a deal to acquire cancer therapy developer Biopharma Global. Its asset-...

October 3, 2023, 6:33 pm

Takeda's dengue vaccine gets who group's recommendation

American depositary receipts of Takeda pharmaceutical Co. 4502, -1.79% TAK, -2.16% rose more than 1% in...

October 3, 2023, 5:36 pm

Novartis positioning is now best-suited for long-term gains and returns after spin-off, says ceo

Novartis CEO Vas Narasimhan joins 'Squawk on the Street' to discuss the company's new spin-off Sandoz, what a pure-play core ...

October 3, 2023, 12:08 pm

Eli lilly buys point biopharma to boost its cancer-fighting therapies

Shares of POINT Biopharma Global (PNT) skyrocketed over 80% in early trading on Tuesday after Eli Lilly (LLY) agreed to buy the radio...

October 3, 2023, 12:00 pm

Are medical stocks lagging exact sciences (exas) this year?

Here is how Exact Sciences (EXAS) and Anebulo pharmaceuticals, Inc. (ANEB) have performed compared to t...

October 3, 2023, 11:16 am

Navigating acumen's alzheimer's risk and reward

Acumen pharmaceuticals' ACU193 shows promise as a potential treatment for early-stage Alzheimer's Disea...

October 3, 2023, 11:03 am

Point biopharma shares storm ahead 84% after eli lily's $1.4bn bid

Shares in Point Biopharma Global jumped 84% following the announcement that pharmaceutical giant Eli Li...

October 3, 2023, 9:05 am


Search within

Pages Search Results: